期刊
DRUG DELIVERY AND TRANSLATIONAL RESEARCH
卷 8, 期 5, 页码 1460-1470出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s13346-018-0540-6
关键词
Resveratrol; Nanostructured lipid carrier; Gellan gum; In situ gel; Nasal route
资金
- Deanship of Scientific Research at Princess Nourah bint Abdulrahman University [RG-1438-002]
The purpose of conducting the present research work was to develop resveratrol nanostructured in situ gel for the treatment of Alzheimer's disease. Resveratrol loaded lipid carrier was prepared by melt emulsification-probe sonication method, and the final product was evaluated for particle size (132 +/- 11.90 nm), polydispersity index (0.209 +/- 0.005), zeta potential (-23 +/- 3.79 mV), drug loading (9.26 +/- 3.79%), and entrapment efficiency (74 +/- 11.40%). Following incorporation of the resveratrol nanostructured lipid carrier in gellan gum and xanthan gum, in situ gel was formulated and characterized. The optimized in situ gel showed fivefold higher permeation across the nasal mucosa as compared to resveratrol suspension-based in situ gel. Finally, optimized in situ gel was evaluated using in vivo pharmacodynamic study by the scopolamine-induced amnesia model in rats using Morris Water Maze test. It showed significant improvement in memory function in rats treated with optimized in situ gel as compared to orally administered resveratrol suspension. The enhanced permeation across nasal mucosa and improved memory function suggest that the resveratrol nanostructured lipid carrier-based in situ gel could be an effective and promising approach for the treatment of Alzheimer's disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据